Arteris (NASDAQ: AIP) CEO logs tax-driven stock sales after RSU release

Rhea-AI Filing Summary

Arteris, Inc. President and CEO Charles K. Janac, who is also a director and 10% owner, reported sales of company common stock on January 2, 2026. He sold 3,185, 1,618, and 3,020 shares of Arteris common stock at a price of $15.4471 per share, with the filing stating that the shares were sold to satisfy his tax liability arising from the release of restricted stock units. After these transactions, he directly beneficially owned 150,632 shares of common stock. The filing also reports indirect beneficial ownership of 9,469,071 shares through Bayview Legacy, LLC, where he is the manager with voting and dispositive power, and 56,252 shares held by the Charles and Lydia Janac Trust, for which he serves as trustee.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JANAC K CHARLES

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		S(1)		3,185	D	$15.4471	155,270	D
Common Stock	01/02/2026		S(1)		1,618	D	$15.4471	153,652	D
Common Stock	01/02/2026		S(1)		3,020	D	$15.4471	150,632	D
Common Stock								9,469,071	I	Bayview Legacy, LLC(2)
Common Stock								56,252	I	Charles and Lydia Janac Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units.

2. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.

3. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for JANAC K CHARLES	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Arteris (AIP) disclose in this Form 4?

The Form 4 reports that Charles K. Janac, President, CEO, director and 10% owner of Arteris, Inc., sold blocks of the company’s common stock on January 2, 2026. The reported sales were 3,185, 1,618, and 3,020 shares of common stock.

At what price were the Arteris (AIP) shares sold by Charles Janac?

The reported sales by Charles K. Janac on January 2, 2026 were executed at a price of $15.4471 per share of Arteris common stock.

Why did Charles Janac sell Arteris (AIP) shares according to the Form 4 footnotes?

A footnote explains that the shares were sold to satisfy the reporting person’s tax liability arising as a result of the release of restricted stock units. This indicates the sales were tied to tax obligations from RSU vesting.

How many Arteris (AIP) shares does Charles Janac own directly after the reported sales?

Following the reported transactions on January 2, 2026, Charles K. Janac directly beneficially owned 150,632 shares of Arteris common stock.

What indirect holdings in Arteris (AIP) does Charles Janac report?

The filing shows indirect beneficial ownership of 9,469,071 Arteris common shares through Bayview Legacy, LLC, where he is the manager with voting and dispositive power, and 56,252 shares held by the Charles and Lydia Janac Trust, for which he serves as trustee.

What is Charles Janac’s role at Arteris (AIP) as noted in the Form 4?

The Form 4 identifies Charles K. Janac as a director, President and CEO, and a 10% owner of Arteris, Inc..